Brandão Sara Michelly Gonçalves, Issa Victor Sarli, Ayub-Ferreira Silvia Moreira, Storer Samantha, Gonçalves Bianca Gigliotti, Santos Valter Garcia, Carvas Junior Nelson, Guimarães Guilherme Veiga, Bocchi Edimar Alcides
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, SP, BR.
Arq Bras Cardiol. 2015 Sep;105(3):265-75. doi: 10.5935/abc.20150076. Epub 2015 Jul 21.
Polypharmacy is a significant economic burden.
We tested whether using reverse auction (RA) as compared with commercial pharmacy (CP) to purchase medicine results in lower pharmaceutical costs for heart failure (HF) and heart transplantation (HT) outpatients.
We compared the costs via RA versus CP in 808 HF and 147 HT patients followed from 2009 through 2011, and evaluated the influence of clinical and demographic variables on cost.
The monthly cost per patient for HF drugs acquired via RA was $10.15 (IQ 3.51-40.22) versus $161.76 (IQ 86.05‑340.15) via CP; for HT, those costs were $393.08 (IQ 124.74-774.76) and $1,207.70 (IQ 604.48-2,499.97), respectively.
RA may reduce the cost of prescription drugs for HF and HT, potentially making HF treatment more accessible. Clinical characteristics can influence the cost and benefits of RA. RA may be a new health policy strategy to reduce costs of prescribed medications for HF and HT patients, reducing the economic burden of treatment.
多重用药是一项重大的经济负担。
我们测试了与商业药房（CP）相比，采用反向拍卖（RA）购买药物是否能降低心力衰竭（HF）和心脏移植（HT）门诊患者的药品成本。
我们比较了2009年至2011年随访的808例HF患者和147例HT患者通过RA与CP购买药物的成本，并评估了临床和人口统计学变量对成本的影响。
通过RA购买的HF药物每位患者每月成本为10.15美元（四分位数间距3.51 - 40.22美元），而通过CP为161.76美元（四分位数间距86.05 - 340.15美元）；对于HT，这些成本分别为393.08美元（四分位数间距124.74 - 774.76美元）和1207.70美元（四分位数间距604.48 - 2499.97美元）。
RA可能降低HF和HT的处方药成本，有可能使HF治疗更容易获得。临床特征可影响RA的成本和效益。RA可能是一种新的卫生政策策略，以降低HF和HT患者的处方药成本，减轻治疗的经济负担。
